Perspektywy rozwoju odpowiedzialności cywilnej – zagadnienia wybrane odpowiedzialności za inteligentne roboty

Bosek, Leszek

doi:10.32082/fp.v2i52.200

Cited by 3 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Wydaje się, że na obecnym etapie rozwoju przepisów dotyczących badań klinicznych możemy jednak postawić wstępną tezę, że do ich prowadzenia konieczne jest zastosowanie szeregu nowych przepisów, regulacji oraz standardów, w zakresie znacznie wykraczającym poza dotychczas stosowaną praktykę 6 . Innymi słowy, w celu prowadzenia badań klinicznych zgodnie z prawem i zasadami etyki (ang.…”

Section: Autorzy Przeprowadzają Wstępną Ocenę Nowej Regulacji O Badan...unclassified

See 1 more Smart Citation

Badania kliniczne wyrobów medycznych wykorzystujących inteligentne algorytmy – wstęp do dyskusji

Stelmasiak¹,

Świerczyński²,

Więckowski³

2022

PwD

View full text Add to dashboard Cite

The authors of the paper carry out a preliminary assessment of the new regulation on clinical trials of medical devices in the context of software based on intelligent algorithms (so-called AI systems). The primary source of law here is the EU Medical Device Regulation (MDR). The study highlights the need to take into account the regulations on artificial intelligence systems when conducting clinical trials. It is justified by their close relationship with the EU provisions on medical devices. The main difficulty in making a legal and ethical assessment of new solutions used in medical devices is the application of various, sometimes divergent, regulations in the field of new technologies and medical law. The study contains preliminary, necessarily balanced and careful, bearing in mind the need to protect patients - research participants (and other people), conclusions on the application of the above provisions in the conduct of clinical trials.

show abstract

Section: Autorzy Przeprowadzają Wstępną Ocenę Nowej Regulacji O Badan...unclassified

“…W czasie powstania artykułu projekt ustawy znajdował się po pierwszym czytaniu: https://www.sejm. gov.pl/sejm9.nsf/PrzebiegProc.xsp?nr=1764 (dostęp: 10.02.2022 r.) 6. Zob.…”

unclassified

Badania kliniczne wyrobów medycznych wykorzystujących inteligentne algorytmy – wstęp do dyskusji

Stelmasiak¹,

Świerczyński²,

Więckowski³

2022

PwD

View full text Add to dashboard Cite

show abstract

“…The issue of liability for damage caused by the use of artificial intelligence systems comes to the fore. Artificial intelligence is now the subject of regulations designed by European Union (hereinafter: the "EU") 2 -along with ethical considerations 3 . Fundamental questions are raised about the optimal regime of liability for harm caused by AI systems and responsible persons 4 .…”

Section: Introductory Remarksmentioning

confidence: 99%

Liability for damages caused by artificial intelligence systems – main challenges to be addressed by the European Union conflict-of-laws regulations

Świerczyński¹,

Więckowski²

2023

PwD

View full text Add to dashboard Cite

This article discusses the main challenges related to the liability for damages caused by artificial intelligence (AI) systems that need to be properly addressed by the European Union (EU) conflict-of-laws regime. In the first part of the paper authors point out three main challenges, namely: 1) determination of responsible persons, 2) optimal liability regime for AI torts, and 3) determination of high – risk AI systems. In the second part of the paper the authors assess the application of the conflict-of-law provisions of the Rome II Regulation from this perspective. This article argues that a harmonised legal framework at EU level is necessary to avoid the risk of legal fragmentation in filling the gaps created by unprecedented technological advances caused by AI. This objective should also be pursued by the conflict-of-laws rules of private international law.

show abstract

Legal Possibilities of Using AI in Medicine, with Particular Emphasis on Imaging Diagnostics and Responsibility of Medical Entities – Polish Perspective

Król-Całkowska

Walczak

2022

TKP

View full text Add to dashboard Cite

The method/practise of providing healthcare services has been significantly modified due to the development of the pandemic. In everyday medical practice, the use of telecommunication media has begun to be widely used, which enable the provision of healthcare services at a distance. The next step is the use of artificial intelligence during the planning, implementation and control of medical activities, which will support and even replace humans at various stages of medical activities. The article discusses issues related to the use of artificial intelligence in the process of medical activities, referring the above to the perspective of current legal regulations. Considering the nature of civilization diseases, the paper refers to the use of AI on the basis of imaging diagnostics constituting the basis for cancer diagnosis and therapy. The choice of this broad topic was motivated by the indications of the latest literature, which emphasize that malignant tumor is the most common cause of death in developed countries and it is estimated that the number of cases will continue to increase in aging populations. The article is one of the first attempts to analyze the principles of using AI in medicine and the principles of its liability for potential damage. The authors used the method of analyzing the applicable regulations, including regulations under European law, and also made a synthetic analysis of the position of the judicature and doctrine. The article indicates that the liability for damage caused by AI should be identified with liability for a dangerous product. At the same time, the civil liability of the medical entity for damages resulting from the use of AI in the diagnostic imaging process will be subject to the general regime of tort liability.

show abstract

Perspektywy rozwoju odpowiedzialności cywilnej – zagadnienia wybrane odpowiedzialności za inteligentne roboty

Cited by 3 publications

References 0 publications

Badania kliniczne wyrobów medycznych wykorzystujących inteligentne algorytmy – wstęp do dyskusji

Badania kliniczne wyrobów medycznych wykorzystujących inteligentne algorytmy – wstęp do dyskusji

Liability for damages caused by artificial intelligence systems – main challenges to be addressed by the European Union conflict-of-laws regulations

Legal Possibilities of Using AI in Medicine, with Particular Emphasis on Imaging Diagnostics and Responsibility of Medical Entities – Polish Perspective

Contact Info

Product

Resources

About